These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2016-002067-33||COBALT: Coversin Global Study: An Open-Label, Safety and Efficacy Trial in PNH Patients||2017-12-21||due-trials|
|Reported results Terminated||2016-004129-18||CONSERVE: Coversin Long Term Safety and Efficacy Surveillance Study||2020-06-22||due-trials|
|Reported results Terminated||2017-000064-15||A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects||2019-04-17||due-trials|
|Exempt, with results Terminated||2017-002835-40||Topical rVA576 for treatment of atopic keratoconjunctivitis: a randomised placebo double masked parallel trial (TRACKER) rVA576 tópico para el tratamiento de la queratoconjuntivitis atópica: un ens...||2020-12-15||not-yet-due|
|Reported results||2017-002836-18||A Phase IIa open label single arm study of safety and efficacy of rVA576 in adult mild to moderate Bullous Pemphigoid subjects||2020-04-29||due-trials|
|Reported results||2017-003847-39||CAPSTONE: Phase III Confirmatory Assessment Protocol: rVA576 Safety and Efficacy in Three-Part, Two-Arm, Randomised Open Label Evaluation in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH)||2020-09-03||due-trials|
|Other||2020-000086-17||Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy||not-yet-due|
|Ongoing||2020-005987-67||A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphi...||not-yet-due|